CONQUEZA Trademark

Trademark Overview


On Thursday, May 5, 2016, a trademark application was filed for CONQUEZA with the United States Patent and Trademark Office. The USPTO has given the CONQUEZA trademark a serial number of 87026072. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The CONQUEZA trademark is filed in the Pharmaceutical Products category with the following description:

Contraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the treatment and prevention of disorders of the sensory organs; Pharmaceuticals and medicines for the treatment and prevention of disorders of the central nervous system; Pharmaceuticals and medicines for the treatment and prevention of disorders of t...
conqueza

General Information


Serial Number87026072
Word MarkCONQUEZA
Filing DateThursday, May 5, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2017

Trademark Statements


Goods and ServicesContraceptive preparations; Hormone replacement therapy preparations; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the treatment and prevention of disorders of the sensory organs; Pharmaceuticals and medicines for the treatment and prevention of disorders of the central nervous system; Pharmaceuticals and medicines for the treatment and prevention of disorders of the urogenital organs; Pharmaceuticals and medicines for the treatment and prevention of disorders of the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular diseases and blood pressure; Pharmaceuticals preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; all the foregoing pharmaceuticals for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 10, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events


Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 25, 2019EXTENSION 5 GRANTED
Tuesday, October 22, 2019EXTENSION 5 FILED
Tuesday, October 22, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 24, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 22, 2019TEAS EXTENSION RECEIVED
Saturday, April 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2019EXTENSION 4 GRANTED
Thursday, April 18, 2019EXTENSION 4 FILED
Thursday, April 18, 2019TEAS EXTENSION RECEIVED
Saturday, October 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 18, 2018EXTENSION 3 GRANTED
Thursday, October 18, 2018EXTENSION 3 FILED
Thursday, October 18, 2018TEAS EXTENSION RECEIVED
Friday, April 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 18, 2018EXTENSION 2 GRANTED
Wednesday, April 18, 2018EXTENSION 2 FILED
Wednesday, April 18, 2018TEAS EXTENSION RECEIVED
Wednesday, April 18, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 18, 2017EXTENSION 1 GRANTED
Wednesday, October 18, 2017EXTENSION 1 FILED
Wednesday, October 18, 2017TEAS EXTENSION RECEIVED
Tuesday, April 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 20, 2017EXAMINER'S AMENDMENT ENTERED
Friday, January 20, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 20, 2017EXAMINERS AMENDMENT E-MAILED
Friday, January 20, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, January 9, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 23, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, July 23, 2016NON-FINAL ACTION E-MAILED
Saturday, July 23, 2016NON-FINAL ACTION WRITTEN
Tuesday, July 19, 2016ASSIGNED TO EXAMINER
Tuesday, May 10, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 9, 2016NEW APPLICATION ENTERED IN TRAM